-
1
-
-
0344188096
-
An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
-
Bischoff J R, Kirn DH, Williams A et al. (1996) An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274: 373-376
-
(1996)
Science
, vol.274
, pp. 373-376
-
-
Bischoff, J.R.1
Kirn, D.H.2
Williams, A.3
-
2
-
-
0042268107
-
Oncolytic viruses for genetic therapy of gastrointestinal tumors
-
Bitzer M, Lauer UM (2003) Oncolytic viruses for genetic therapy of gastrointestinal tumors. Z Gastroenterol 7: 667-674
-
(2003)
Z Gastroenterol
, vol.7
, pp. 667-674
-
-
Bitzer, M.1
Lauer, U.M.2
-
3
-
-
0035871639
-
T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein
-
Butterfield LH, Meng WS, Koh A et al. (2001) T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein. J Immunol 166: 5300-5308
-
(2001)
J Immunol
, vol.166
, pp. 5300-5308
-
-
Butterfield, L.H.1
Meng, W.S.2
Koh, A.3
-
4
-
-
7044226216
-
Immunotherapeutic strategies for hepatocellular carcinoma
-
Butterfield LH (2004) Immunotherapeutic strategies for hepatocellular carcinoma. Gastroenterology 127: S232-S241
-
(2004)
Gastroenterology
, vol.127
-
-
Butterfield, L.H.1
-
5
-
-
29144474459
-
Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma
-
Eckel F, von Delius S, Mayr M et al. (2005) Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma. Oncology 69: 363-371
-
(2005)
Oncology
, vol.69
, pp. 363-371
-
-
Eckel, F.1
von Delius, S.2
Mayr, M.3
-
6
-
-
0034797669
-
Immunotherapy directed against alpha-fetoprotein results in autoimmune liver disease during liver regeneration in mice
-
Geissler M, Mohr L, Köhler G et al. (2001) Immunotherapy directed against alpha-fetoprotein results in autoimmune liver disease during liver regeneration in mice. Gastroenterology 121: 931-939
-
(2001)
Gastroenterology
, vol.121
, pp. 931-939
-
-
Geissler, M.1
Mohr, L.2
Köhler, G.3
-
7
-
-
0033769892
-
Mouse alpha-fetoprotein- specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice
-
Grimm CF, Ortmann D, Mohr L et al. (2000) Mouse alpha-fetoprotein- specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice. Gastroenterology 119: 1104-1112
-
(2000)
Gastroenterology
, vol.119
, pp. 1104-1112
-
-
Grimm, C.F.1
Ortmann, D.2
Mohr, L.3
-
8
-
-
85047699490
-
-
Habib N, Salama H, Abd El Latif Abu Median A et al. (2002) Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma. Cancer Gene Ther 9: 254-259
-
Habib N, Salama H, Abd El Latif Abu Median A et al. (2002) Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma. Cancer Gene Ther 9: 254-259
-
-
-
-
9
-
-
9644255742
-
Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma
-
Hopfner M, Sutter AP, Huether A et al. (2004) Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma. J Hepatol 41: 1008-1016
-
(2004)
J Hepatol
, vol.41
, pp. 1008-1016
-
-
Hopfner, M.1
Sutter, A.P.2
Huether, A.3
-
10
-
-
0037384518
-
A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer
-
Iwashita Y, Tahara K, Goto S et al. (2003) A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer. Cancer Immunol Immunother, 52: 155-161 2003
-
(2003)
Cancer Immunol Immunother
, vol.52
, pp. 155-161
-
-
Iwashita, Y.1
Tahara, K.2
Goto, S.3
-
11
-
-
0034868947
-
Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro
-
Krohne TU, Shankara S, Geissler M et al. (2001) Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro. Hepatology 34: 511-518
-
(2001)
Hepatology
, vol.34
, pp. 511-518
-
-
Krohne, T.U.1
Shankara, S.2
Geissler, M.3
-
12
-
-
12144286051
-
Phase II randomized trial of autologous formalin-fixed tumor vaccine for postsurgical recurrence of hepatocellular carcinoma
-
Kuang M, Peng BG, Lu MD et al. (2004) Phase II randomized trial of autologous formalin-fixed tumor vaccine for postsurgical recurrence of hepatocellular carcinoma. Clin Cancer Res 10: 1574-1579
-
(2004)
Clin Cancer Res
, vol.10
, pp. 1574-1579
-
-
Kuang, M.1
Peng, B.G.2
Lu, M.D.3
-
13
-
-
0037295403
-
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
-
Liu BL, Robinson M, Han ZQ et al. (2003) ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties. Gene Ther 10: 292-303
-
(2003)
Gene Ther
, vol.10
, pp. 292-303
-
-
Liu, B.L.1
Robinson, M.2
Han, Z.Q.3
-
15
-
-
0034212631
-
Oncolysis of diffuse hepatocellular carcinoma by intravascular administration of a replication-competent, genetically engineered herpesvirus
-
Pawlik TM, Nakamura, H, Yoon SS et al. (2000) Oncolysis of diffuse hepatocellular carcinoma by intravascular administration of a replication-competent, genetically engineered herpesvirus. Cancer Res 60: 2790-2795
-
(2000)
Cancer Res
, vol.60
, pp. 2790-2795
-
-
Pawlik, T.M.1
Nakamura, H.2
Yoon, S.S.3
-
16
-
-
27244447373
-
Phase II study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer
-
Philip PA, Mahoney MR, Allmer C et al. (2005) Phase II study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer. J Clin Oncol 23: 6657-6663
-
(2005)
J Clin Oncol
, vol.23
, pp. 6657-6663
-
-
Philip, P.A.1
Mahoney, M.R.2
Allmer, C.3
-
17
-
-
2342570309
-
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors
-
Sangro B, Mazzolini G, Ruiz J et al. (2004) Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors. J Clin Oncol 22: 1389-1397
-
(2004)
J Clin Oncol
, vol.22
, pp. 1389-1397
-
-
Sangro, B.1
Mazzolini, G.2
Ruiz, J.3
-
20
-
-
20044382799
-
Phase I clinical and pharmacokinetic study of the novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors
-
Strumberg D, Richly H, Hilger RA et al. (2005) Phase I clinical and pharmacokinetic study of the novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors. J Clin Oncol 23: 965-972
-
(2005)
J Clin Oncol
, vol.23
, pp. 965-972
-
-
Strumberg, D.1
Richly, H.2
Hilger, R.A.3
-
21
-
-
0034596475
-
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: A randomised trial
-
Takayama T, Sekine T, Makuuchi M et al. (2000) Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 356: 802-807
-
(2000)
Lancet
, vol.356
, pp. 802-807
-
-
Takayama, T.1
Sekine, T.2
Makuuchi, M.3
-
22
-
-
32944480899
-
Opportunities for targeted therapies in hepatocellular carcinoma
-
Thomas MB, Abbruzzese JL (2005) Opportunities for targeted therapies in hepatocellular carcinoma. J Clin Oncol 23: 8093-8108
-
(2005)
J Clin Oncol
, vol.23
, pp. 8093-8108
-
-
Thomas, M.B.1
Abbruzzese, J.L.2
-
23
-
-
0031890627
-
Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration
-
Wada Y, Nakashima O, Kutami R et al. (1998) Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 27: 407-414
-
(1998)
Hepatology
, vol.27
, pp. 407-414
-
-
Wada, Y.1
Nakashima, O.2
Kutami, R.3
-
24
-
-
0035177693
-
Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene
-
Wybranietz WA, Gross CD Phelan A et al. (2001) Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene. Gene Ther 8: 1654-1664
-
(2001)
Gene Ther
, vol.8
, pp. 1654-1664
-
-
Wybranietz, W.A.1
Gross, C.D.2
Phelan, A.3
-
25
-
-
0001642806
-
Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene
-
Xu G. W, Sun ZT, Forrester K et al. (1996) Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene. Hepatology 24: 1264-1268
-
(1996)
Hepatology
, vol.24
, pp. 1264-1268
-
-
Xu, G.W.1
Sun, Z.T.2
Forrester, K.3
-
26
-
-
0036320613
-
Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors
-
Zender L, Kock R, Eckhard M et al. (2002) Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors. Gastroenterology 123: 608-618
-
(2002)
Gastroenterology
, vol.123
, pp. 608-618
-
-
Zender, L.1
Kock, R.2
Eckhard, M.3
|